This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acosta PB, Yannicelli (2001) The Ross metabolic formula system, nutrition support protocols, 4th edn. Ross Products Division, Abbott Laboratories, Columbus, OH
Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J, Baas F (1999) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome). J Inherit Metab Dis 22:555–567
Berry GT, Heidenreich R, Kaplan P, Levine F, Mazur A, Palmieri MJ, Yudkoff M, Segal S (1991) Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease. N Engl J Med 324:175–179
Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1971–2005
Costeff H, Gadoth N, Apter N, Prialnic M, Savir H (1989) Afamilial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology 39:595–597
Dasouki M, Buchanan D, Mercer N, Gibson KM, Thoene J (1987) 3-Hydroxy-3-methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction. J Inherit Metab Dis 10:142–146
Elpeleg ON, Costeff H, Joseph A, Shental Y, Weitz R, Gibson KM (1994) 3-Methylglutaconic aciduria in the Iraqi-Jewish “optic atrophy plus” (Costeff) syndrome. Dev Med Child Neurol 36:167–172
Fries MH, Rinaldo P, Schmidt-Sommerfeld E, Jurecki E, Packman S (1996) Isovaleric acidemia: response to a leucine load after 3 weeks of supplementation with glycine, L-carnitine, and combined glycine-carnitine therapy. J Pediatr 129:449–452
Gibson KM, Breuer J, Nyhan WL (1988) 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Review of 18 reported patients. Eur J Pediatr 148:180–186
Gibson KM, Bennett MJ, Naylor EW, Morton DH (1998) 3-Methylcrotonyl-coenzyme Acarboxylase deficiency inAmish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr 132:519–523
Jouvet P, Jugie M, Rabier D, Desgres J, Hubert P, Saudubray J, Man NK (2001) Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med 27:1798–806
Kaplan P, Mazur A, Field M, Berlin JA, Berry GT, Heidenreich R, Yudkoff M, Segal S (1991) Intellectual outcome in children with maple syrup urine disease. J Pediatr 119:46–50
Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI (2002) Diagnosis and treatment of maple syrup disease: A study of 36 patients. Pediatrics 109:999–1008
Naglak M, Salvo R, Madsen K, Dembure P, Elsas L (1988) The treatment of isovaleric acidemia with glycine supplement. Pediatr Res 24:9–13
Ogier de Baulny H, Saudubray JM (2002) Branched-chain organic acidurias. Semin Neonatol 7:65–74
Ostman-Smith I, Brown G, Johnson A, Land JM (1994) Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid. Br Heart J 72:349–353
Sousa C de, Chalmers RA, Stacey TE, Tracey BM, Weaver CM, Bradley D (1986) The response to l-carnitine and glycine therapy in isovaleric acidaemia. Eur J Pediatr 144:451–456
Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341
Sweetman L, Williams JC (2001) Branched-chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2125–2163
Thompson GN, Chalmers RA, Halliday D (1990) The contribution of protein catabolism to metabolic decompensation in 3-hydroxy-3-methylglutaric aciduria. Eur J Pediatr 149:346–350
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wappner, R.S., Gibson, K.M. (2006). Disorders of Leucine Metabolism. In: Blau, N., Leonard, J., Hoffmann, G.F., Clarke, J.T.R. (eds) Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28962-3_8
Download citation
DOI: https://doi.org/10.1007/3-540-28962-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22954-4
Online ISBN: 978-3-540-28962-3
eBook Packages: MedicineMedicine (R0)